Articles > Leukemia

  1. FDA Approval of New Treatment Option for Children with Secondary Acute Myeloid Leukemia is a Welcome Step Forward

    Here at The Leukemia & Lymphoma Society (LLS), we applaud every advance for children with blood cancers. Today's reason to celebrate is the news that the U.S. Food and Drug Administration (FDA) expanded the approval of daunorubicin and cytarabine (Vyxeos®) to include treatment of pediatric patients aged one year and older with newly-diagnosed therapy-related acute myeloid leukemia (t-AML) or AML with myelodysplasia-related changes (AML-MRC). This is a welcome and necessary advancement in...

    Read More
  1. Meet the Researcher: Omar Abdel-Wahab, MD

    This is part of a periodic series of Q&A’s with LLS-funded researchers. Dr. Abdel-Wahab of Memorial Sloan Kettering Cancer Center focuses on an area of research called epigenetics – chemical modifications that regulate (switch on and off) gene activity. He is studying how these processes drive the development of acute myeloid leukemia and other blood cancers. He currently holds a Career Development Program grant from LLS, a program that supports scientists earlier in their careers...

    Read More
  2. Another Advance for AML

    The steady pace of progress in treating patients with acute myeloid leukemia (AML), still one of the most deadly blood cancers, continued with today’s U.S. Food & Drug Administration’s second approval of a drug called ivosidenib (Tibsovo) that works for patients with a specific subtype of AML. In another win for precision medicine, where therapies are matched to a patient’s specific genetic profile, the FDA approved ivosidenib for newly diagnosed patients 75-years-of-age and ...

    Read More
  3. Achieving the Impossible: What’s ahead in 2018?

    We’ve just concluded one of the most historic years on record in terms of new therapy approvals for blood cancers. In all, the U.S. Food and Drug Administration (FDA) approved 18 therapies to treat patients with blood cancers, including some entirely new agents and some new uses for already approved drugs. Among these approvals were the first new therapies – four to be precise – for acute myeloid leukemia (AML) after a 40-year drought in treatment advances for this deadly blood c...

    Read More
  1. Revolutionary, Lifesaving Immunotherapy Takes Significant Step Toward FDA Approval

    Today is a very significant day in the progress toward cancer cures. An advisory committee of the U.S. Food & Drug Administration (FDA) unanimously recommended approval of a revolutionary new treatment for patients with relapsed/refractory acute lymphoblastic leukemia (ALL) – an immunotherapy called CAR-T (chimeric antigen receptor T-cell) immunotherapy. The Leukemia & Lymphoma Society recognized the early promise of this new approach, which uses the body’s own immune system to...

    Read More
  2. Lodging & Transportation Resources for Cancer Survivors

    By Margaret Martin, RD, MS, LDN, Licensed Dietitian and Nutritionist; Certified Diabetes Educator, PearlPoint Cancer Support As part of cancer treatment, you may make frequent trips to your cancer treatment center for appointments and treatment. If your treatment center isn’t close to home, this may mean extra transportation and lodging expenses. Many resources are available to cancer patients to help cover the costs of travel for treatment. The first step is to talk to your healt...

    Read More
  3. What is Medicare?

    By Abby Henry, Oncology Content Manager, PearlPoint Cancer Support Medicare is an insurance program run by the United States government. Medicare is for people who 65 years or older Under 65 but have received Social Security Disability Insurance (SSDI) for 24 months Have end-stage renal disease or Amyotrophic Lateral Sclerosis (ALS) Medicare has 4 types of possible coverage. Part A (Hospital Insurance): Part A covers inpatient care such as hospital care, nursin...

    Read More
  4. Is Your Food Safe?

    By Margaret Martin, RD, MS, LDN, Licensed Dietitian and Nutritionist; Certified Diabetes Educator, PearlPoint Cancer Support Food safety is a valuable goal year-round but especially in the warmer months. Why? More people travel and transport food during the vacation months. The outside temperatures in summer and early autumn often leave outdoor food in the danger zone, between 40 degrees and 140 degrees. Food eaten at outdoor events like picnics, tailgates, and cookouts are at a higher...

    Read More
  5. Am I Depressed?

    Do you ever feel sad, withdrawn, or blue? Did these feelings appear or become more pronounced after your or your loved one’s diagnosis? If so, you are not alone. Many patients and caregivers report feeling down during the course of a cancer journey. These feelings can arise when adjusting to a new diagnosis or changes in relationships. They can also arise while adjusting to life after treatment or living as a “survivor”, even many years later. Identity challenges or emotions such as gui...

    Read More
  6. Caregiver Spotlight: Using Writing to Heal and Cope

    Caregiving can cause a roller coaster of emotions that change over time. Finding time and outlets to cope is not always easy. Dr. Robert Winn, medical director of Deer Valley and The Canyons in Park City, knows this struggle all too well. Life was near perfect for Dr. Winn and his beloved wife Nancy. When Nancy was diagnosed with acute myeloid leukemia (AML), their world went tumbling out of control. Dr. Winn could not speak of Nancy's illness without getting choked up or crying, so to commun...

    Read More